Childhood‐Onset Filamin c Related Cardiomyopathy: Genotype–Phenotype Correlation and Outcome
Clinical Genetics · 2026-12 · 110 (6) · 724-735
DOI: 10.1111/cge.70248 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Genetics, online erschienen am 13.09.2026. Verfasst von Evelien Cansse und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Pediatric Cardiology, Ghent University Hospital, Ghent, Belgium. Hauptthemen laut MEDLINE: Filamins, Genetic Association Studies, Cardiomyopathies. Die Arbeit nennt 63 Literaturangaben. Gefördert von: Universiteit Gent.
Abstract (Originalsprache)
Filamin C ( FLNC ) contributes to 1%–8% of adult‐onset cardiomyopathy (CMP), with a high prevalence of end‐stage heart failure and sudden cardiac death, particularly for FLNC truncating variants ( FLNCtv ), rendering it one of the high‐risk CMP genes. Outcome data and genotype–phenotype correlation in children are scarce. We conducted a retrospective cohort study of children (< 18 years) with CMP features and a (likely) pathogenic FLNC variant, identified via literature search or in the Belgian Pediatric Cardiology Registry (BePCaR), to evaluate cardiovascular outcomes and genotype–phenotype correlations. Seventy‐four individuals (56.8% male, median age 4.5 years) from 57 families were included. Restrictive CMP was the most prevalent phenotype. Half of the patients experienced major adverse cardiovascular events, including heart transplantation (20.3%) and death (13.5%). Hypertrophic CMP was exclusively associated with ROD2 domain variants. Mortality was significantly higher in FLNCtv carriers versus non‐truncating carriers (26.9% vs. 6.3%, p = 0.019), and multivariate analysis identified FLNCtv as an independent predictor of adverse outcome (OR = 6.4, 95% CI: [1.36, 29.80]). Extracardiac manifestations occurred in 32.4%, predominantly in RCM patients, with myopathy‐associated variants clustering in exons 21 and 41. Pathogenic FLNC variants associate with early‐onset CMP and poor prognosis, underscoring the need for early genetic screening, risk stratification, and personalized follow‐up to improve outcome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Pediatric Cardiology, Ghent University Hospital, Ghent, Belgium.
- Department of Pediatrics, Antwerp University Hospital, Antwerp, Belgium.
- Laboratory of Experimental Medicine and Pediatrics (LEMP), University of Antwerp, Antwerp, Belgium.
- Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium.
- Department of Biomolecular Medicine, Ghent University, Ghent, Belgium.
- Department of Pediatrics, Pediatric Cardiology, Leuven University Hospital, Leuven, Belgium.
ORCID-Profile: Evelien Cansse, Wannes Renders, Luc Bruyndonckx, Bert Callewaert, Katya De Groote, Ruth Heying, Jelena Hubrechts, Stéphane Moniotte, Thomas Salaets, Laura Muiño Mosquera
Förderung
- Universiteit Gent
Zitieren
APA
Cansse, E., Renders, W., Bruyndonckx, L., Callewaert, B., De Groote, K., Heying, R., Hubrechts, J., Moniotte, S., Salaets, T., & Mosquera, L. M. (2026). Childhood‐Onset Filamin c Related Cardiomyopathy: Genotype–Phenotype Correlation and Outcome. Clinical Genetics, 110(6), 724-735. https://doi.org/10.1111/cge.70248
Vancouver
Cansse E, Renders W, Bruyndonckx L, Callewaert B, De Groote K, Heying R, et al. Childhood‐Onset Filamin c Related Cardiomyopathy: Genotype–Phenotype Correlation and Outcome. Clinical Genetics. 2026;110(6):724-735. doi:10.1111/cge.70248
BibTeX
@article{Cansse2026,
author = {Cansse, Evelien and Renders, Wannes and Bruyndonckx, Luc and Callewaert, Bert and De Groote, Katya and Heying, Ruth and Hubrechts, Jelena and Moniotte, Stéphane and Salaets, Thomas and Mosquera, Laura Muiño},
title = {Childhood‐Onset Filamin c Related Cardiomyopathy: Genotype–Phenotype Correlation and Outcome},
journal = {Clinical Genetics},
year = {2026},
volume = {110},
number = {6},
pages = {724--735},
doi = {10.1111/cge.70248}
}
EUVIMED